![](/img/cover-not-exists.png)
Tight control for Crohnâs disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Panaccione, Remo, Colombel, Jean-Frederic, Travis, Simon P L, Bossuyt, Peter, Baert, Filip, VaÅásek, Tomáš, DanalıoÄlu, Ahmet, Novacek, Gottfried, Armuzzi, Alessandro, Reinisch, Walter, Johnson,Volume:
69
Journal:
Gut
DOI:
10.1136/gutjnl-2019-318256
Date:
April, 2020
File:
PDF, 677 KB
2020